skip to main content
Idioma:
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study
A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study
Material Type:
Artigo 		Adicionar ao Meu Espaço

A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study

Levine, John E, Prof ; Braun, Thomas M, Prof ; Harris, Andrew C, MD ; Holler, Ernst, MD ; Taylor, Austin, BA ; Miller, Holly, DO ; Magenau, John, MD ; Weisdorf, Daniel J, Prof ; Ho, Vincent T, MD ; Bolaños-Meade, Javier, MD ; Alousi, Amin M, MD ; Ferrara, James L M, Prof

The Lancet. Haematology, 2015, Vol.2 (1), p.e21-e29 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials

Griffiths, Christopher E M, Prof ; Reich, Kristian, Prof ; Lebwohl, Mark, Prof ; van de Kerkhof, Peter, Prof ; Paul, Carle, Prof ; Menter, Alan, MD ; Cameron, Gregory S, PhD ; Erickson, Janelle, PhD ; Zhang, Lu, MS ; Secrest, Roberta J, PhD ; Ball, Susan, PhD ; Braun, Daniel K, MD ; Osuntokun, Olawale O, MD ; Heffernan, Michael P, MD ; Nickoloff, Brian J, MD ; Papp, Kim, MD

The Lancet (British edition), 2015-08, Vol.386 (9993), p.541-551 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study

Castaigne, Sylvie, Prof ; Pautas, Cécile, MD ; Terré, Christine, MD ; Raffoux, Emmanuel, MD ; Bordessoule, Dominique, Prof ; Bastie, Jean-Noel, Prof ; Legrand, Ollivier, Prof ; Thomas, Xavier, MD ; Turlure, Pascal, MD ; Reman, Oumedaly, MD ; de Revel, Thierry, Prof ; Gastaud, Lauris, MD ; de Gunzburg, Noémie, MD ; Contentin, Nathalie, MD ; Henry, Estelle ; Marolleau, Jean-Pierre, Prof ; Aljijakli, Ahmad, MD ; Rousselot, Philippe, Prof ; Fenaux, Pierre, Prof ; Preudhomme, Claude, Prof ; Chevret, Sylvie, Prof ; Dombret, Hervé, Prof

The Lancet (British edition), 2012-04, Vol.379 (9825), p.1508-1516 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial
Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial

Choi, Sung Won, MD ; Braun, Thomas, Prof ; Chang, Lawrence, MD ; Ferrara, James L M, Prof ; Pawarode, Attaphol, MD ; Magenau, John M, MD ; Hou, Guoqing, PhD ; Beumer, Jan H, PhD ; Levine, John E, Prof ; Goldstein, Steve, MD ; Couriel, Daniel R, Prof ; Stockerl-Goldstein, Keith, MD ; Krijanovski, Oleg I, MD ; Kitko, Carrie, MD ; Yanik, Gregory A, Prof ; Lehmann, Michael H, Prof ; Tawara, Isao, MD ; Sun, Yaping, MD ; Paczesny, Sophie, MD ; Mapara, Markus Y, Prof ; Dinarello, Charles A, Prof ; DiPersio, John F, Prof ; Reddy, Pavan, Prof

The lancet oncology, 2014, Vol.15 (1), p.87-95 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials
Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials

Moran, Antoinette, Prof ; Bundy, Brian, PhD ; Becker, Dorothy J, Prof ; DiMeglio, Linda A, MD ; Gitelman, Stephen E, Prof ; Goland, Robin, Prof ; Greenbaum, Carla J, MD ; Herold, Kevan C, Prof ; Marks, Jennifer B, Prof ; Raskin, Philip, Prof ; Sanda, Srinath, MD ; Schatz, Desmond, Prof ; Wherrett, Diane K, MD ; Wilson, Darrell M, Prof ; Krischer, Jeffrey P, Prof ; Skyler, Jay S, Prof ; Pickersgill, Linda, MD ; de Koning, Eelco, Prof ; Ziegler, Anette-G, Prof ; Böehm, Bernhard, Prof ; Badenhoop, Klaus, Prof ; Schloot, Nanette, MD ; Bak, Jens Friis, MD ; Pozzilli, Paolo, Prof ; Mauricio, Didac, MD ; Donath, Marc Y, Prof ; Castaño, Luis, Prof ; Wägner, Ana, MD ; Lervang, Hans Henrik, MD ; Perrild, Hans, MD ; Mandrup-Poulsen, Thomas, Prof

The Lancet (British edition), 2013-06, Vol.381 (9881), p.1905-1915 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial
Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial

McInnes, Iain B, Prof ; Mease, Philip J, Prof ; Kirkham, Bruce, MD ; Kavanaugh, Arthur, Prof ; Ritchlin, Christopher T, Prof ; Rahman, Proton, Prof ; van der Heijde, Désirée, Prof ; Landewé, Robert, Prof ; Conaghan, Philip G, Prof ; Gottlieb, Alice B, Prof ; Richards, Hanno, MD ; Pricop, Luminita, MD ; Ligozio, Gregory, MSc ; Patekar, Manmath, MD ; Mpofu, Shephard, MD

The Lancet (British edition), 2015-09, Vol.386 (9999), p.1137-1146 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b/3 trial
Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b/3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b/3 trial

Haffizulla, Jason, MD ; Hartman, Aaron, MD ; Hoppers, Melanie, MD ; Resnick, Harvey, MD ; Samudrala, Steve, MD ; Ginocchio, Christine, PhD ; Bardin, Matthew, PharmD ; Rossignol, Jean-François, Prof

The Lancet infectious diseases, 2014-07, Vol.14 (7), p.609-618 [Periódico revisado por pares]

London: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
European guidelines on the clinical management of HIV-1 tropism testing
European guidelines on the clinical management of HIV-1 tropism testing
Material Type:
Artigo 		Adicionar ao Meu Espaço

European guidelines on the clinical management of HIV-1 tropism testing

Vandekerckhove, LPR, MD ; Wensing, AMJ, MD ; Kaiser, R, MD ; Brun-Vézinet, F, Prof ; Clotet, B, MD ; De Luca, A, MD ; Dressler, S, MD ; Garcia, F, PhD ; Geretti, AM, MD ; Klimkait, T, Prof ; Korn, K, MD ; Masquelier, B, PharmD ; Perno, CF, Prof ; Schapiro, JM, MD ; Soriano, V, Prof ; Sönnerborg, A, Prof ; Vandamme, A-M, Prof ; Verhofstede, C, PhD ; Walter, H, MD ; Zazzi, M, MSc ; Boucher, CAB, Prof

The Lancet infectious diseases, 2011-05, Vol.11 (5), p.394-407 [Periódico revisado por pares]

London: Elsevier Ltd

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.